Thalidomide-NH-C2-alkyne contains an E3 ligase ligand with an alkyl linker, and a terminal alkyne. Thalidomide-NH-C2-alkyne is ready for conjugation to target proteins for PROTAC R&D.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > E3 Ligase Ligand-Linker Conjugates
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。